Summary: Big news for Abbott, the makers of the FreeStyle Libre. This summer the he FDA okayed a shorter warmup and a longer wear for the glucose monitor. Stacey talks to Tim Dunn, Abbott’s Director of Clinical research. They talk about the challenge of longer wear, the practical info you need to know if you use the Libre, and a look down the road as they partner with companies like Bigfoot. Plus, a protest planned at the end of the month – all about affordable insulin.
